☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Top Performing Drugs of 2021: A Monthly Series by PharmaShots
April 28, 2022
AstraZeneca’ Ultomiris (ravulizumab-cwvz) Receives the US FDA’s Approval for the Treatment of Generalized Myasthenia Gravis
April 28, 2022
Transcenta Reports First Patient Dosing in P-I Study of TST002 for the Treatment of Osteoporosis in China
April 28, 2022
Amgen Reports Results of Repatha (evolocumab) in P-III (FOURIER) OLE Studies for the Treatment of Atherosclerotic Cardiovascular D...
April 28, 2022
Harmony Biosciences Reports the Initiation of P-III (INTUNE) Withdrawal Study for Pitolisant to Treat Idiopathic Hypersomnia
April 28, 2022
Statera Signs a License Agreement with Immune for Naltrexone and Met-Enkephalin to Treat Immune-Related Diseases
April 28, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions